Novartis AG

Novartis AG Ch-4002 Basle
Locations Update This Record Cases by Outcome Cases by Type	SEC CIK 1114448 Country of Incorporation Switzerland

Add a document

Description
Summary
Document Type	Academic Paper Corporate Document - Internal Corporate Document - Public Court Document Equity Research Government Document - Federal Government Document - State Government Document - Local FBI File Public Records Request Response - FOIA Public Records Request Response - State Non-Profit Report Police Report White Paper
Document Date
Document Source
Source URL
File
	If you would like to be credited for contributing this document, make sure to sign in or sign up first. Once uploaded, your document may not be immediately visible to the public as we review each document for legal issues. Thanks for your patience!

Go Pro to view an analysis and graphs of case roles, types and more.

Filter By From To

	Date Filed	Venue	Case Number	Title	Party Type
	4/10/2025	USPTO Trademark Trial and Appeal Board	98789277-EXT	Novartis Ag v. Regeneron Pharmaceuticals, Inc.	Potential Opposer
	3/10/2025	USPTO Trademark Trial and Appeal Board	98501137-EXT	Novartis Ag v. Scg Cell Therapy Pte Ltd.	Potential Opposer
	2/25/2025	USPTO Trademark Trial and Appeal Board	79369290-EXT	Novartis Ag v. Tokiwa Phytochemical Co., Ltd.	Potential Opposer
	2/25/2025	USPTO Trademark Trial and Appeal Board	79975781-EXT	Novartis Ag v. Tokiwa Phytochemical Co., Ltd.	Potential Opposer
	2/6/2025	USPTO Trademark Trial and Appeal Board	79399423-EXT	Teva Pharmaceuticals Usa, Inc. v. Novartis Ag	Defendant
	12/16/2024	USPTO Trademark Trial and Appeal Board	98484586-EXT	Novartis Ag v. Lp Pharmaceuticals, Inc	Potential Opposer
	11/21/2024	USPTO Trademark Trial and Appeal Board	98415752-EXT	Novartis Ag v. Aotu Technology Co.,ltd	Potential Opposer
	11/5/2024	USPTO Trademark Trial and Appeal Board	98387696-EXT	Novartis Ag v. Nnovar LLC	Potential Opposer
	10/28/2024	USPTO Trademark Trial and Appeal Board	79394512-EXA	In re Novartis Ag, Serial No. 79394512	Plaintiff
	10/11/2024	USPTO Trademark Trial and Appeal Board	98468938-EXT	Novartis Ag v. Elevar Therapeutics, Inc.	Potential Opposer
	7/8/2024	USPTO Trademark Trial and Appeal Board	98433469-EXT	Novartis Ag v. Omeros Corporation	Potential Opposer
	6/26/2024	USPTO Trademark Trial and Appeal Board	98433468-EXT	Astellas Pharma Inc. v. Omeros Corporation	Potential Opposer
	6/25/2024	USPTO Trademark Trial and Appeal Board	79362246-EXT	Novartis Ag v. Stemon Inc.	Potential Opposer
	2/13/2024	USPTO Trademark Trial and Appeal Board	97861523-EXT	Novartis Ag v. Advanced Humeomics LLC	Potential Opposer
	9/5/2017	USPTO Trademark Trial and Appeal Board	87398372-EXT	Concentrx Pharmaceuticals, Inc. v. Novartis Ag, et al	Potential Opposer
	8/23/2017	Florida Southern District Court	2:17-cv-14302	McWilliams v. Novartis AG	Defendant
	8/16/2017	USPTO Trademark Trial and Appeal Board	86932390-EXT	Novartis Ag v. Bausch & Lomb Incorporated	Potential Opposer
	8/7/2017	USPTO Trademark Trial and Appeal Board	91235993-OPP	Jazz Pharmaceuticals, Inc. v. Novartis Ag	Defendant
	7/26/2017	USPTO Trademark Trial and Appeal Board	86902351-EXT	Novartis Ag v. Glaxo Group Limited	Potential Opposer
	7/26/2017	USPTO Trademark Trial and Appeal Board	86902360-EXT	Novartis Ag v. Glaxo Group Limited	Potential Opposer
	7/14/2017	USPTO Trademark Trial and Appeal Board	86089221-EXT	Novartis Ag v. Azanta A/s	Potential Opposer
	7/14/2017	USPTO Trademark Trial and Appeal Board	87334207-EXT	Novartis Ag v. Intra-cellular Therapies, Inc.	Potential Opposer
	7/14/2017	USPTO Trademark Trial and Appeal Board	87334209-EXT	Novartis Ag v. Intra-cellular Therapies, Inc.	Potential Opposer
	6/30/2017	Delaware District Court	1:17-cv-00867	Novartis Pharmaceuticals Corporation et al v. Teva Pharmaceu...	Plaintiff
	6/20/2017	USPTO Trademark Trial and Appeal Board	87320935-EXT	Novartis Ag v. Abbvie Biotechnology Ltd.	Potential Opposer
	6/19/2017	USPTO Trademark Trial and Appeal Board	87276280-EXT	Novartis Ag v. Johnson & Johnson	Potential Opposer
	6/15/2017	USPTO Trademark Trial and Appeal Board	87232880-EXT	Janssen Biotech, Inc v. Novartis Ag	Defendant
	6/15/2017	USPTO Trademark Trial and Appeal Board	87311918-EXT	Novartis Ag v. Corbus Pharmaceuticals, Inc.	Potential Opposer
	6/13/2017	USPTO Trademark Trial and Appeal Board	87324607-EXT	Novartis Ag v. Dauus Company Llc	Potential Opposer
	6/6/2017	Pennsylvania Eastern District Court	2:17-cv-02552	KPH HEALTHCARE SERVICES, INC. v. FOUGERA PHARMACEUTICALS, IN...	Defendant
	6/6/2017	Pennsylvania Eastern District Court	2:17-cv-02554	KPH HEALTHCARE SERVICES, INC. v. LANNETT COMPANY, INC. et al	Defendant
	6/1/2017	Pennsylvania Eastern District Court	2:17-cv-02476	KPH HEALTHCARE SERVICES, INC. v. FOUGERA PHARMACEUTICALS INC...	Defendant
	6/1/2017	Pennsylvania Eastern District Court	2:17-cv-02477	KPH HEALTHCARE SERVICES, INC. v. FOUGERA PHARMACEUTICALS, IN...	Defendant
	5/30/2017	USPTO Trademark Trial and Appeal Board	91234784-OPP	Novartis Ag v. Leadiant Biosciences Limited	Plaintiff
	5/22/2017	USPTO Trademark Trial and Appeal Board	87201770-EXT	Novartis Ag v. Galway Licensing Pty Ltd.	Potential Opposer
	4/26/2017	Pennsylvania Eastern District Court	2:17-cv-01911	TEAMSTERS LOCAL UNION NO. 727 HEALTH & WELFARE FUND v. MYLAN...	Defendant
	4/13/2017	Delaware District Court	1:17-cv-00420	Novartis Pharmaceuticals Corporation et al v. Breckenridge P...	Plaintiff
	4/13/2017	Delaware District Court	1:17-cv-00420	Novartis Pharmaceuticals Corporation et al v. Breckenridge P...	Counter defendant
	4/12/2017	Pennsylvania Eastern District Court	2:17-cv-01665	FWK HOLDINGS, L.L.C. et al v. LANNETT COMPANY, INC. et al	Defendant
	4/12/2017	Pennsylvania Eastern District Court	2:17-cv-01667	CESAR CASTILLO, INC. et al v. SANDOZ, INC. et al	Defendant
	4/12/2017	Pennsylvania Eastern District Court	2:17-cv-01668	CESAR CASTILLO, INC. v. FOUGERA PHARMACEUTICALS, INC. et al	Defendant
	4/12/2017	Pennsylvania Eastern District Court	2:17-cv-01663	FWK HOLDINGS, L.L.C. v. FOUGERA PHARMACEUTICALS, INC. et al	Defendant
	4/12/2017	Pennsylvania Eastern District Court	2:17-cv-01662	FWK HOLDINGS, L.L.C. v. FOUGERA PHARMACEUTICALS, INC. et al	Defendant
	4/10/2017	West Virginia Northern District Court	1:17-cv-00054	Novartis Pharmaceuticals Corporation v. Mylan Pharmaceutical...	Plaintiff
	4/10/2017	West Virginia Northern District Court	1:17-cv-00054	Novartis Pharmaceuticals Corporation v. Mylan Pharmaceutical...	Counter defendant
	4/7/2017	Delaware District Court	1:17-cv-00393	Novartis Pharmaceuticals Corporation v. Teva Pharmaceuticals...	Plaintiff
	4/7/2017	Delaware District Court	1:17-cv-00389	Novartis Pharmaceuticals Corporation v. Mylan Pharmaceutical...	Plaintiff
	4/7/2017	Delaware District Court	1:17-cv-00389	Novartis Pharmaceuticals Corporation v. Mylan Pharmaceutical...	Counter defendant
	4/5/2017	USPTO Trademark Trial and Appeal Board	79192250-EXT	Novartis Ag v. Farmaceutici Damor S.p.a.	Potential Opposer
	3/30/2017	USPTO Trademark Trial and Appeal Board	87224101-EXT	Novartis Ag v. Impleo Medical, Inc.	Potential Opposer

992 Rows Total	Page 1 of 20 | Go To

Inside Counsel (0)

Go Pro to view corporate inside counsel.

Outside Counsel (777)

	Last Name	First Name	Middle Name	Firm	Location
				Morgan, Lewis & Bockius, LLP	CHICAGO, IL
				Saul Ewing LLP	WAYNE, PA
				Finnegan, Henderson, Farabow, Garrett & Dunn...	Washington, DC
					San Diego, CA
				Finnegan, Henderson, Farabow, Garrett & Dunn...	Washington, DC
		ALCON		Baker Botts, LLP	DALLAS, TX
		Novartis		Corporate Intellectual Property	East Hanover, NJ
		NOVARTIS			East Hanover, NJ
		Novartis		CORPORATION, INTELLECTUAL PROPERTY	East Hanover, NJ
		Novartis		CORPORATE INTELECTUAL PROPERTY	East Hanover, NJ
		Novartis		CORPORATE INTELLECTUA PROPERTY	East Hanover, NJ
		SEQIRUS		Finnegan, Henderson, Farabow, Garrett & Dunn...	Washington, DC
		SYNGENTA		Patent & Trademark Dept	RESEARCH TRIANGLE PARK, NC
		Syngenta
	Aannestad	Anders	Tingulstad	Morrison & Foerster, LLP	TUCSON,
	Abrams	Franklin	S.		ALBANY, NY
	Ackerman	Lily	J.	Morrison & Foerster, LLP	San Francisco, CA
	ADAMS	LINDA		Novartis Pharmaceuticals Corporation	EAST HANOVER, NJ
	ADMINISTRATOR	PATENT		Goodwin Procter, LLP
	Ag	Novartis			Ch-4002 Basel Switzerland,
	Ag	Novartis	Pharma		Basel, Switzerland
	Agensky	Adam	R.	Novartis Corporation	East Hanover, NJ
	Agthe	Thilo	C.		New York, NY
	Alexander	John	B.	400 Technology Square	CAMBRIDGE, MA
	Alexander	John	B.	Novartis Institute For Biomedical Research, ...	CAMBRIDGE, MA
	Alexander	John		Novartis Institute For Biomedical Research, ...	CAMBRIDGE, MA
	ALEXANDER	JOHN			CAMBRIDGE, MA
	Alexander	John	B.		CAMBRIDGE, MA
	Alyonycheva	Tatiana	N.	Arnold & Porter, LLP
	Ambrose	Robert	A.	CIBA Vision Corporation	Duluth, GA
	Ambrose	Robert	A.		Neenah,
	AMBROSE	ROBERT
	Amrhein	Alexandra
	Anania	Mark	H.	McCarter & English LLP	NEWARK, NJ
	ANDERSON	DUSTIN			CAMBRIDGE, MA
	Anderson	Ryan	E.	Larson & Anderson, LLC	Dillon, CO
	Anderson	Ryan	E.		DILLON, CO
	Andrea	Brian	Kent	Gibson Dunn & Crutcher, LLP
	Antonacci	Peter	V.	Gray Robinson	TALLAHASSEE, FL
	Anzalone	Teresa	H.	gsk.com Law Firm Placeholder	King Of Prussia, PA
	Arbor	Ann			ANN ARBOR, MI
	Attorney	Unknown		Baker & McKenzie, LLP	Beaverton, OR
	Attorney	Unknown		Morrison & Foerster, LLP	Ae Eindhoven, NL
	Avenue	564	Morris		Summit, NJ
	Avenue	605	Third	Suite 3500	New York, NY
	Axenfeld	Robert	R.	Montgomery McCracken Walker & Rhoads, LLP	PHILADELPHIA, PA
	B.	Ph.d.	John	400 Technology Square	CAMBRIDGE, MA
	B.	Ph.d.	John	Corporate Intellectual Property	EAST HANOVER, NJ
	Backam	Vanessa		alcon.com Law Firm Placeholder	Fort Worth, TX
	Backman	Vanessa		haiwaiqiao.com Law Firm Placeholder	Fort Worth, TX
	Baechtold	Robert	Louis	Fitzpatrick, Cella, Harper & Scinto	New York, NY
	Bailey	Amber
	Barakat	Barbara	A.	Wilmer Hale, LLP
	Bargmann	Kelly	M.	Ostrolenk Faber LLP	New York, NY
	Barnett	Scott	D.		Chicago, IL
	Baron	Mark		Novartis Institute For Biomedical Research, ...	CAMBRIDGE, MA
	Baron	Mark	E.	Novartis Institute For Biomedical Research, ...	CAMBRIDGE, MA
	Baron	Mark	E.		Syosset, NY
	Barr	David	Keith	Arnold & Porter, LLP	New York, NY
	Bassinger	Kenneth	D.	Alcon Researh, Ltd., Ip Legal	Fort Worth, TX
	Bassinger	Kenneth	D.	Alcon Research, Ltd., Ip Legal	Fort Worth, TX
	Bassinger	Kenneth	D.		FORT WORTH, TX
	Bassler	Marc	Benedict	Caesar, Rivise, Bernstein, Cohen & Pokotilow...	PHILADELPHIA, PA
	BATES	NAFRA			EMERYVILLE, CA
	Baum	John	C.	Kilpatrick Townsend & Stockton, LLP
	BAUTISTA	REGINA		Novartis Vaccines & Diagnostics, Inc.	Emeryville, CA
	BAUTISTA	REGINA			Emeryville, CA
	BEAUDET	MATTHEW			BOSTON, MA
	BENNI	MEI		Novartis Institute For Biomedical Research, ...	CAMBRIDGE, MA
	Beran	Martin	J.	Ostrolenk Faber LLP	New York, NY
	Berry	Andrew	T.	McCarter & English LLP	New York , NY
	Betti	Christopher	J.	Morgan, Lewis & Bockius, LLP	San Francisco, CA
	Bevisuire	John	W.	finch-law.com Law Firm Placeholder	Sao Paulo,
	BINET-CROSS	SOPHIE			CAMBRIDGE, MA
	Biologicals	Sa	Glaxosmithkline	GLOBAL PATENTS UP4110	Collegeville, PA
	Biotecchnology	Novartis	Agribusiness	Research, Inc.
	Biotechnology	Novartis	Agrlbusiness	Patent & Trademark Dept	DURHAM, NC
	Biotechnology	Novartis	Agribusiness	Research, Inc.
	Biotechnology	Novartis	Agribusiness		DURHAM, NC
	Biotechnology	Novartis		Patent & Trademark Dept	RESEARCH TRIANGLE PARK, NC
	Biotechnology	Novartis	Agribusiness	Research Inc., Patent & Trademark Dept	Research Triangle Park, NC
	BLAKE	ALISON			CAMBRIDGE, MA
	BLAKE	ALLISON		400 Technology Square	CAMBRIDGE, MA
	BLAKE	ALLISON		Novartis Institute For Biomedical Research, ...	CAMBRIDGE, MA
	BLAKE	ALLISON			CAMBRIDGE, MA
	Blakely	Lauren	V.
	Blofield	Tiffany	A.	Winthrop & Weinstine, PA	Chicago, IL
	Bofill	Adam		Dentons (US) LLP	Palo Alto, CA
	Boisson	Patrick		Fross Zelnick Lehrman & Zissu, PC	New York, NY
	Bosch	Michele
	Bosman	Erin	M.	Morrison & Foerster, LLP
	Boudreaux	William	R.		ANN ARBOR, MI
	Boyd	David	W.	Kilpatrick Townsend & Stockton, LLP	San Francisco, CA
	Boyle	Stephanie		Alcon Laboratories Inc.	Fort Worth, TX
	Bradney	Alice		GSK GLOBAL PATENTS UP4110	Collegeville, PA
	Bronzi	Luca	Roberto	bronzipa.com Law Firm Placeholder	North Miami Beach, FL
	Bullock	Dashonna			Arlington, VA
	Buroker	Brian	Mark	Gibson Dunn & Crutcher, LLP
	Byrd	Warren	E.	Louisiana Department of Justice	Baton Rouge, LA
	Caldwell	Lisa	M.	Klarquist Sparkman, LLP	Or,

777 Rows Total	Page 1 of 8 | Go To

Filter By Form All Records 20-F 3 3/A 4 4/A 424B2 424B3 424B5 425 5 6-K 6-K/A CORRESP CT ORDER DFAN14A EFFECT F-3 F-3ASR F-4 F-4/A F-6EF FWP IRANNOTICE POSASR S-8 S-8 POS SC 13D SC 13D/A SC 13E3 SC 13E3/A SC 13G SC 13G/A SC TO-C SC TO-T SC TO-T/A SD UPLOAD From To

	Date	Entity	Form Number	Description
	11/5/2025		6-K	Report of foreign private issuer pursuant to Rule 13a-16 or 15d-...
	11/4/2025		FWP	Filing under Securities Act Rules 163/433 of free writing prospe...
	11/4/2025		424B5
	11/3/2025		424B5
	10/28/2025		SC TO-T/A
	10/28/2025		DFAN14A
	10/28/2025		DFAN14A
	10/28/2025		6-K	Report of foreign private issuer pursuant to Rule 13a-16 or 15d-...
	10/28/2025		3	Initial statement of beneficial ownership of securities
	10/27/2025		DFAN14A
	10/27/2025		DFAN14A
	10/27/2025		DFAN14A
	10/27/2025		6-K	Report of foreign private issuer pursuant to Rule 13a-16 or 15d-...
	10/22/2025		SC TO-T/A
	10/20/2025		SC TO-T/A
	9/30/2025		6-K	Report of foreign private issuer pursuant to Rule 13a-16 or 15d-...
	9/29/2025		SC TO-T
	9/9/2025		SC TO-C
	8/11/2025		6-K	Report of foreign private issuer pursuant to Rule 13a-16 or 15d-...
	7/17/2025		SCHEDULE 13G
	7/17/2025		6-K	Report of foreign private issuer pursuant to Rule 13a-16 or 15d-...
	7/17/2025		6-K	Report of foreign private issuer pursuant to Rule 13a-16 or 15d-...
	6/25/2025		SC TO-T/A
	6/23/2025		SC TO-T/A
	6/17/2025		SC TO-T/A
	6/2/2025		6-K	Report of foreign private issuer pursuant to Rule 13a-16 or 15d-...
	5/23/2025		144	Notice of proposed sale of securities pursuant to Rule 144 under...
	5/1/2025		SC TO-C
	4/30/2025		SC TO-C
	4/30/2025		144	Notice of proposed sale of securities pursuant to Rule 144 under...
	4/29/2025		6-K	Report of foreign private issuer pursuant to Rule 13a-16 or 15d-...
	4/8/2025		UPLOAD
	4/3/2025		6-K	Report of foreign private issuer pursuant to Rule 13a-16 or 15d-...
	3/31/2025		CORRESP
	3/28/2025		6-K	Report of foreign private issuer pursuant to Rule 13a-16 or 15d-...
	3/18/2025		UPLOAD
	1/31/2025		IRANNOTICE
	1/31/2025		6-K	Report of foreign private issuer pursuant to Rule 13a-16 or 15d-...
	1/31/2025		6-K	Report of foreign private issuer pursuant to Rule 13a-16 or 15d-...
	1/31/2025		20-F
	12/30/2024		6-K	Report of foreign private issuer pursuant to Rule 13a-16 or 15d-...
	11/25/2024		6-K	Report of foreign private issuer pursuant to Rule 13a-16 or 15d-...
	10/29/2024		6-K	Report of foreign private issuer pursuant to Rule 13a-16 or 15d-...
	10/29/2024		6-K	Report of foreign private issuer pursuant to Rule 13a-16 or 15d-...
	10/17/2024		SC 13D/A
	9/18/2024		6-K	Report of foreign private issuer pursuant to Rule 13a-16 or 15d-...
	9/17/2024		6-K	Report of foreign private issuer pursuant to Rule 13a-16 or 15d-...
	9/17/2024		424B5
	9/16/2024		FWP	Filing under Securities Act Rules 163/433 of free writing prospe...
	9/16/2024		F-3ASR

1,396 Rows Total	Page 1 of 28 | Go To

	Date Recorded	Party	Role	Document Type	Document No.	Invention Title
	5/13/2025	Alcon Laboratories, Inc.	Assignor	Application Publication	18959960 20250082418
	5/13/2025	Alcon Inc.	Assignee	Application Publication	18959960 20250082418
	4/18/2025	Novartis Institutes For Biomedical Resea...	Assignor	Application Publication	18434265 20240317840	Hepatitis B Antibodies Hepatitis B Antibodies
	4/10/2025	Alcon Research, Ltd.	Assignor	Application Publication	18390201 20240122699	Systems And Processes For Inserting An Intraocular Lens Systems And Processes For Inserting An Intraocular Lens
	4/7/2025	Esbatech	Assignor	Application Publication Patent	13000499 20110200594 8637022	Functionalized Polypeptides Functionalized Polypeptides Functionalized Polypeptides
	4/4/2025	Novartis Pharma Ag	Assignor	Application Publication	18597624 20240317878	Regimens And Methods Of Treating Multiple Sclerosis Using Ofatumumab Regimens And Methods Of Treating Multiple Sclerosis Using Ofatumumab
	4/4/2025	Novartis Pharmaceuticals Corporation	Assignor	Application Publication	18597624 20240317878
	3/31/2025	Hofstetter, Hans	Assignor	Application Publication	18647368 20250122277	Interleukin-17 (il-17) Antagonistic Antibodies Interleukin-17 (il-17) Antagonistic Antibodies
	3/31/2025	Di Padova, Franco E.	Assignor	Application Publication	18647368 20250122277	Interleukin-17 (il-17) Antagonistic Antibodies Interleukin-17 (il-17) Antagonistic Antibodies
	3/31/2025	Van Den Berg, Wim	Assignor	Application Publication	18647368 20250122277	Interleukin-17 (il-17) Antagonistic Antibodies Interleukin-17 (il-17) Antagonistic Antibodies
	3/31/2025	Rondeau, Jean-michel	Assignor	Application Publication	18647368 20250122277	Interleukin-17 (il-17) Antagonistic Antibodies Interleukin-17 (il-17) Antagonistic Antibodies
	3/31/2025	Gramm, Hermann	Assignor	Application Publication	18647368 20250122277	Interleukin-17 (il-17) Antagonistic Antibodies Interleukin-17 (il-17) Antagonistic Antibodies
	3/31/2025	Jeschke, Margit	Assignor	Application Publication	18647368 20250122277	Interleukin-17 (il-17) Antagonistic Antibodies Interleukin-17 (il-17) Antagonistic Antibodies
	3/27/2025	Genentech, Inc.	Assignor	Application Publication	18762543 20250011474	ANTI-IgE ANTIBODY THERAPY FOR MULTIPLE FOOD ALLERGIES ANTI-IgE ANTIBODY THERAPY FOR MULTIPLE FOOD ALLERGIES
	3/26/2025	Novartis Institute For Functional Genomi...	Assignor	Application Publication	18937914 20250064964	Antibody Drug Conjugates For Ablating Hematopoietic Stem Cells Antibody Drug Conjugates For Ablating Hematopoietic Stem Cells
	3/26/2025	Novartis Institutes For Biomedical Resea...	Assignor	Application Publication	18937914 20250064964	Antibody Drug Conjugates For Ablating Hematopoietic Stem Cells Antibody Drug Conjugates For Ablating Hematopoietic Stem Cells
	3/26/2025	Novartis Institute For Functional Genomi...	Assignor	Application Publication	18937914 20250064964	Antibody Drug Conjugates For Ablating Hematopoietic Stem Cells Antibody Drug Conjugates For Ablating Hematopoietic Stem Cells
	3/26/2025	Morphosys Ag	Assignor	Application Publication	18937914 20250064964	Antibody Drug Conjugates For Ablating Hematopoietic Stem Cells Antibody Drug Conjugates For Ablating Hematopoietic Stem Cells
	3/26/2025	China Novartis Institutes For Biomedical...	Assignor	Application Publication	18937914 20250064964	Antibody Drug Conjugates For Ablating Hematopoietic Stem Cells Antibody Drug Conjugates For Ablating Hematopoietic Stem Cells
	3/26/2025	Novartis Institute For Functional Genomi...	Assignor	Application Publication	18937914 20250064964	Antibody Drug Conjugates For Ablating Hematopoietic Stem Cells Antibody Drug Conjugates For Ablating Hematopoietic Stem Cells
	3/24/2025	Novartis Pharma Ag	Assignor	Application Publication	18288345 20240384293	Viral Vector Production System Viral Vector Production System
	3/22/2025	Novartis Pharma Ag	Assignor	Application Publication	18800977 20250034241	Selective Reduction Of Cysteine Residues In Il-17 Antibodies Selective Reduction Of Cysteine Residues In Il-17 Antibodies
	3/22/2025	Sandoz Ag	Assignor	Application Publication	18800977 20250034241	Selective Reduction Of Cysteine Residues In Il-17 Antibodies Selective Reduction Of Cysteine Residues In Il-17 Antibodies
	3/14/2025	Novartis Pharma Ag	Assignor	Application Publication	18391485 20250026858
	3/14/2025	Novartis Pharma Ag	Assignor	Application Publication	18638545 20240425617	Method Of Manufacturing Bispecific Antibodies, Bispecific Antibodies And... Method Of Manufacturing Bispecific Antibodies, Bispecific Antibodies And...
	3/11/2025	Alcon Research, Ltd.	Assignor	Application Publication	18958272 20250082462	Ophthalmic Lens Having An Extended Depth Of Focus Ophthalmic Lens Having An Extended Depth Of Focus
	3/11/2025	Alcon Inc.	Assignee	Application Publication	18958272 20250082462	Ophthalmic Lens Having An Extended Depth Of Focus Ophthalmic Lens Having An Extended Depth Of Focus
	3/10/2025	Novartis Institutes For Biomedical Resea...	Assignor	Application Application Publication Publication	16759251 16759251 20200370012 20200370012
	3/10/2025	The Trustees Of The University Of Pennsy...	Assignee	Application Application Publication Publication	16759251 16759251 20200370012 20200370012
	3/10/2025	The Trustees Of The University Of Pennsy...	Assignor	Application Application Publication Publication	16759251 16759251 20200370012 20200370012	Methods Of Making Chimeric Antigen Receptor-expressing Cells Methods Of Making Chimeric Antigen Receptor-expressing Cells Methods Of Making Chimeric Antigen Receptor-expressing Cells Methods Of Making Chimeric Antigen Receptor-expressing Cells
	3/5/2025	Novartis Pharma Ag	Assignor	Application Publication	18434265 20240317840
	3/5/2025	Novartis Institute For Biomedical Resear...	Assignor	Application Publication	18434265 20240317840
	3/4/2025	Sandoz Ag	Assignor	Application Publication	18800977 20250034241
	3/4/2025	Novartis Pharma Ag	Assignor	Application Publication	18800977 20250034241
	3/3/2025	Advanced Accelerator Applications	Assignor	Application Publication	18819282 20250099634	Method Of Treating Cancer Method Of Treating Cancer
	3/3/2025	Advanced Accelerator Applications Intern...	Assignor	Application Publication	18819282 20250099634
	3/3/2025	Advanced Accelerator Applications (italy...	Assignor	Application Publication	18819282 20250099634	Method Of Treating Cancer Method Of Treating Cancer
	3/3/2025	Novartis Pharmaceuticals Corporation	Assignor	Application Publication	18819282 20250099634	Method Of Treating Cancer Method Of Treating Cancer
	3/3/2025	Novartis Pharma Ag	Assignor	Application Publication	18819282 20250099634	Method Of Treating Cancer Method Of Treating Cancer
	3/3/2025	Advanced Accelerator Applications	Assignor	Application Publication	18819282 20250099634	Method Of Treating Cancer Method Of Treating Cancer
	3/3/2025	Advanced Accelerator Applications Intern...	Assignor	Application Publication	18819282 20250099634	Method Of Treating Cancer Method Of Treating Cancer
	3/3/2025	Advanced Accelerator Applications Usa, I...	Assignor	Application Publication	18819282 20250099634	Method Of Treating Cancer Method Of Treating Cancer
	3/3/2025	Advanced Accelerator Applications (italy...	Assignor	Application Publication	18819282 20250099634	Method Of Treating Cancer Method Of Treating Cancer
	3/3/2025	Novartis Pharmaceuticals Corporation	Assignor	Application Publication	18819282 20250099634	Method Of Treating Cancer Method Of Treating Cancer
	3/3/2025	Novartis Pharma Ag	Assignor	Application Publication	18819282 20250099634	Method Of Treating Cancer Method Of Treating Cancer
	3/3/2025	Advanced Accelerator Applications Usa, I...	Assignor	Application Publication	18819282 20250099634	Method Of Treating Cancer Method Of Treating Cancer
	2/27/2025	Novartis Pharmaceuticals Uk Ltd.	Assignor	Application Publication	18634286 20250034240	Il-18 Binding Molecules Il-18 Binding Molecules
	2/27/2025	Morphosys Ag	Assignor	Application Publication	18634286 20250034240
	2/27/2025	Novartis Pharma Ag	Assignor	Application Publication	18634286 20250034240
	2/26/2025	The Trustees Of The University Of Pennsy...	Assignor	Application Application Publication Publication	17799171 17799171 20230111593 20230111593
	2/24/2025	Novartis Pharmaceuticals Corporation	Assignor	Application Publication	17271430 20220364055	Methods Of Making Chimeric Antigen Receptor-expressing Cells Methods Of Making Chimeric Antigen Receptor-expressing Cells
	2/24/2025	Novartis Institutes For Biomedical Resea...	Assignor	Application Publication	17271430 20220364055
	2/24/2025	Novartis Pharma Ag	Assignor	Application Publication	17271430 20220364055
	2/21/2025	Novartis Institutes For Biomedical Resea...	Assignor	Application Publication	18422517 20250002499

54 Rows Total

	Date Recorded	Party	Role	Document Type	Document No.	Image
	3/31/2025	F. Hoffmann-la Roche Ag	Assignee	Application	88883801
	3/31/2025	F. Hoffmann-la Roche Ag	Assignee	Trademark	7037469
	3/31/2025	F. Hoffmann-la Roche Ag	Assignee	Application	88883802
	3/31/2025	F. Hoffmann-la Roche Ag	Assignee	Trademark	6980800
	1/2/2025	F. Hoffmann-la Roche Ag	Assignee	Trademark	6635253
	1/2/2025	F. Hoffmann-la Roche Ag	Assignee	Application	79314628
	2/29/2024	Beigene Switzerland GmbH	Assignee	Trademark	5537974
	2/29/2024	Beigene Switzerland GmbH	Assignee	Application	79228266
	2/29/2024	Beigene Switzerland GmbH	Assignee	Application	79323568
	2/29/2024	Beigene Switzerland GmbH	Assignee	Trademark	6763024
	2/29/2024	Beigene Switzerland GmbH	Assignee	Trademark	6763025
	2/29/2024	Beigene Switzerland GmbH	Assignee	Application	79323622

12 Rows Total

Parent Entities

• Aeglea Biotherapeutics, Inc.
• Aileron Therapeutics, Inc.
• Alnylam Pharmaceuticals, Inc.
• Avexis, Inc.
• CHIRON CORP
• EastBridge Investment Group Corp
• Eon Labs, Inc.
• Galera Therapeutics, Inc.
• Healthcare Acquisition Corp
• Idenix Pharmaceuticals Inc.
• Intellia Therapeutics, Inc.
• Momenta Pharmaceuticals, Inc.
• Nastech Pharmaceutical Co Inc
• Novartis Bioventures Ltd.
• Novartis Corp
• NOVARTIS Inc.
• Novartis Institutes for BioMedical Research, Inc.
• Proteostasis Therapeutics, Inc.
• Ra Pharmaceuticals, Inc.
• Talaris Therapeutics, Inc.
• Tokai Pharmaceuticals, Inc.
• Zeta Acquisition Corp II

Corporate Family (88)

Track Corporate Family

• Aeglea Biotherapeutics, Inc., None
• Aileron Therapeutics, Inc., None
• Alnylam Pharmaceuticals, Inc., None
• Avexis, Inc., None
• CHIRON CORP, None
• EastBridge Investment Group Corp, None
• Eon Labs, Inc., None
• Galera Therapeutics, Inc., None
• Healthcare Acquisition Corp, None
• Idenix Pharmaceuticals Inc., None
• Intellia Therapeutics, Inc., None
• Momenta Pharmaceuticals, Inc., None
• Nastech Pharmaceutical Co Inc, None
• Novartis, Related
• Novartis (cayman) Limited, Related
• Novartis (novartis Agriculture Discovery Institute), Related
• Novartis Agribusiness Biotechnology Research, Inc., Related
• Novartis Animal Health, Related
• Novartis Animal Health Australasia Pty Ltd., Related
• Novartis Animal Health Canada, Inc., Related
• Novartis Animal Health Inc., Related
• Novartis Animal Health K.K., Related
• Novartis Animal Health UK Ltd., Related
• Novartis Animal Health US, Inc., Related
• Novartis Biotech Partnership, Inc., Related
• Novartis Bioventure Fund / Novartis International Aig, Related
• Novartis Bioventures Ltd., None
• Novartis Bioventures Ltd., Related
• Novartis Centre De Recherche Sante Animale Sa, Related
• Novartis Consumer Health S.a., Related
• Novartis Consumer Health UK Ltd., Related
• Novartis Consumer Health, Inc., Related
• Novartis Corp, None
• Novartis Corporate Intellectual Property, Related
• Novartis Corporation, Related
• Novartis Crop Protection, Inc., Related
• Novartis Finance Corporation, Related
• Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research, Related
• Novartis Healthcare Private Ltd., Related
• NOVARTIS Inc., None
• NOVARTIS Inc., Related
• Novartis Influenza Vaccines Marburg GmbH, Related
• Novartis Insititute For Tropical Diseases Pte Ltd, Related
• Novartis Institute For Biomedical Research, Inc., Related
• Novartis Institute For Functional Genomics, Inc., Related
• Novartis Institute For Tropical Diseases Pte Ltd, Related
• Novartis Institutes for BioMedical Research, Inc., None
• Novartis International AG, Related
• Novartis International Pharmaceuticals Ltd., Related
• Novartis Nutrition AG, Related
• Novartis Nutrition Corporation, Related
• Novartis Nutrition Ltd., Related
• Novartis Nutrtion Ag, Related
• Novartis Ophthalmics Ag, Related
• Novartis Pharamaceuticals Corporation, Related
• Novartis Pharma Ag, Related
• Novartis Pharma GmbH, Related
• Novartis Pharma Intellectual Property, Related
• Novartis Pharma K.K., Related
• Novartis Pharma S.a.s., Related
• Novartis Pharma Stein Ag, Related
• Novartis Pharmaceuticals Corp. Legal Department, Related
• Novartis Pharmaceuticals Corporation, Related
• Novartis Pharmaceuticals UK Ltd., Related
• Novartis Pharmas S.a.s., Related
• Novartis Rorschungsstiftung, Zweigniederlassung, Froedrich Miescher Institute For Biomedoca Research, Related
• Novartis Seeds BV, Related
• Novartis Seeds, Inc., Related
• Novartis Services, Inc., Related
• Novartis Sverige Participations Aktiebolag, Related
• Novartis Taiwan, Related
• Novartis Tiergeshundheit Ag, Related
• Novartis Tiergesundheit Ag, Related
• Novartis Vaccine And Diagnostics Srl., Related
• Novartis Vaccines & Diagnostics, Inc., Related
• Novartis Vaccines And Diagnostics GmbH & Company KG, Related
• Novartis Vaccines And Diagnostics, Inc. Emeryville Diagnostics, Related
• Novartis Vaccines And Diagnostics, Ltd., Related
• Novartis Vaccines And Diagnostics, S.r.l., Related
• Novartis Vaccines And Dignostics, Srl, Related
• Novartis Vaccines Influenza S.r.l., Related
• Novartis Vaccines Institute For Global Health, Related
• Novartis Vaccines Institute For Global Health S.r.l, Related
• Proteostasis Therapeutics, Inc., None
• Ra Pharmaceuticals, Inc., None
• Talaris Therapeutics, Inc., None
• Tokai Pharmaceuticals, Inc., None
• Zeta Acquisition Corp II, None

Subsidiaries

• NOVARTIS Inc.
• Novartis Bioventures Ltd.
• Novartis Institutes for BioMedical Research, Inc.
• Novartis Corp

Sign in to add additional links.

Incoming Payments

This organization has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This organization has not disclosed any outgoing payments to lobbying groups.